Schedule 13D ownership disclosure

COCRYSTAL PHARMA INC

Security class unavailable · CUSIP: 19188J102

Event date: 2014-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
100,269,114
Percent of class
47.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-14-002601
Form type
SC 13D
Filer
Cocrystal Pharma, Inc.
CIK
CIK 1412486
Filed
Aug 21, 2014
Reporting period
Aug 11, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub